Barclays’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Barclays’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-161	Closed	-$2K	–	7978
2014 Q3	$2K	Sell	161 -100	-38%	-$1.49K	﹤0.01%	7476
2014 Q2	$4K	Sell	261 -98	-27%	-$1.46K	﹤0.01%	7249
2014 Q1	$5K	Buy	359 +67	+23%	+$878	﹤0.01%	7244
2013 Q4	$3K	Sell	292 -198	-40%	-$2.08K	﹤0.01%	7328
2013 Q3	$4K	Sell	490 -160	-25%	-$1.33K	﹤0.01%	7083
2013 Q2	$5K	Buy	+650	New	+$4.77K	﹤0.01%	7381

Barclays's DRTX Position: Q4 2014 in Review

Barclays sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 161 shares — an estimated $2K sold.

Barclays first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $5K in Q1 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Barclays reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Barclays sold 161 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $2K.
Barclays first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
Barclays's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $5K in Q1 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.